ATTENTION: Please enable Javascript in your browser for full site functionality.
Skip to navigation Skip to main content Skip to footer

Important update on operations in Eastern Europe

AmerisourceBergen - March 15, 2022

Leaders at AmerisourceBergen continue to monitor the international response and reaction to Russia’s invasion of Ukraine.

All operations in Ukraine remain suspended to ensure the safety of our team members, partners and customers. AmerisourceBergen will cease new business initiatives in Russia and Belarus while completing support of existing clinical trials and continuing distribution of oncology therapies and other pharmaceutical products.

We will continue to share more information as soon as it is available. Please keep checking this page for further updates. If you have any additional questions, please reach out to your local World Courier representative.

For more information about AmerisourceBergen’s current operations in Eastern Europe, please read this statement from Robert Mauch, Executive Vice President and Group President of AmerisourceBergen.